BMRN   $57.44  -1.83% Market Closed After Close 54.5 -5.12%

BioMarin Pharmaceutical Inc.

EMA (20): 2026-10-29 the price crossed up the moving average line and formed a short-term upside trend.

EMA (50): 2026-10-30 the price crossed up the moving average line and formed a short-term upside trend.

EMA (100): 2026-09-24 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

RSI: RSI indicator is in the lower part of the neutral territory and it heading south. These factors indicate that negative dynamics is recovering. Last signal: exit from the overbought zone.

MACD: Oscillator MACD is in the positive territory it's higher than the signal line and it crossed the zero line from the bottom. These factors mean that there is probably a growing trend. Last signal: up-crossing the middle level.

Stochastic: The stochastic indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: main and signal line crossing.

Trend Type up and flat
Power almost flat
Trend Pattern
EMA (20) Signals bullish reversal
EMA (20) Yield 1.77%
EMA (20) date of signal Oct. 29, 2026, 3 a.m.
EMA (50) Signals bullish reversal
EMA (50) Yield 0.0
EMA (50) date of signal Oct. 30, 2026, 3 a.m.
EMA (100) Signals bearish reversal
EMA (100) Yield -4.63%
EMA (100) date of signal Sept. 24, 2026, 3 a.m.
RSI Signals bullish weakening
RSI (14) Yield 0.0
RSI (14) date of signal Oct. 31, 2026, 3 a.m.
MACD Signals bullish
MACD Yield 0.0
MACD date of signal Nov. 1, 2026, 3 a.m.
Stochastic Signals bullish weakening
Stochastic Yield 0.0
Stochastic date of signal Nov. 1, 2026, 3 a.m.
Updated Nov. 1, 2026, 11 p.m.